Delivery Order SPE2DR25D3501-SPE2DR26FM1VR
- Not listed
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $7.62 thousand to supply Lidocaine 5% Patch 30s, with an ultimate completion date of January 7, 2026. The contract utilizes a firm fixed-price structure and was competitively awarded without a set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial...
- The Defense Logistics Agency awarded a delivery order valued at $28,326.18 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,534.53 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of December 17, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,437.38 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units under a firm fixed-price contract. The award was competitively procured without set-aside provisions and is scheduled for completion by June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $11,843.67. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $30,239.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to support federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a key supplier through...
- The Defense Logistics Agency awarded a delivery order valued at $9,208.23 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with an ultimate completion date of December 23, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a maximum value...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,387.34 for Lidocaine 5% patches (30-count units) by the Defense Logistics Agency on December 31, 2025. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 2, 2026. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $33,574.73 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM1VRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,540.62 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, operating as a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor that supplies prescription medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to meet procurement requirements through open competition, with this particular award reflecting the routine supply of pain management pharmaceuticals to support military and veteran healthcare systems. The non-set-aside designation indicates the contract was competitively awarded on a full and open basis to qualified bidders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||